ADCT-602
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for ADCT-602, covering 2025-12-12 to 2025-12-12. Get the full timeline:
Most recent: Clinical Trial Update: ADCT-602 in Treating Patients With Recurrent or Refractory B-cell Acute Lymphoblastic Leukemia [Phase 1, Phase 2]